| iPSC-Derived Motor Neurons | |
|---|---|
| Lineage | Stem Cell > iPSC > Motor Neuron |
| Markers | CHAT, ISL1, HB9, SMI-32, TUBB3 |
| Brain Regions | In Vitro (Spinal Cord Patterning) |
| Disease Relevance | Amyotrophic Lateral Sclerosis (ALS), Spinal Muscular Atrophy (SMA) |
| Protocol | Directed Differentiation (21-30 days) |
Ipsc Derived Motor Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
iPSC-Derived Motor Neurons are specialized neurons generated from induced pluripotent stem cells (iPSCs) through directed differentiation protocols that recapitulate embryonic spinal cord development.1 These cells express characteristic motor neuron markers including CHAT (choline acetyltransferase), ISL1, HB9 (MNX1), and neurofilament (SMI-32), defining their identity as authentic motor neurons.2
iPSC-derived motor neurons provide a powerful in vitro model for studying amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), and other motor neuron diseases.3 These cells can be generated from patients with familial ALS mutations (C9orf72, SOD1, FUS, TARDBP) as well as sporadic cases, enabling disease modeling in a patient-specific context.4
The generation of motor neurons from iPSCs typically follows a directed differentiation approach that mimics embryonic spinal cord development:
iPSC-derived motor neurons are characterized by the following marker expression profile:
| Marker | Type | Function |
|---|---|---|
| HB9 (MNX1) | Transcription Factor | Motor neuron specification |
| ISL1 | Transcription Factor | Motor neuron survival |
| CHAT | Enzyme | Acetylcholine synthesis |
| SMI-32 | Neurofilament | Axonal integrity |
| TUBB3 (βIII-tubulin) | Cytoskeleton | Neuronal identity |
| MAP2 | Cytoskeleton | Dendritic marking |
iPSC-derived motor neurons from ALS patients exhibit several pathological features:
iPSC-derived motor neurons are commonly co-cultured with:
iPSC-derived motor neurons are being developed for transplantation therapy:
iPSC-derived motor neurons serve as platforms for:
| Cell Source | Advantages | Limitations |
|---|---|---|
| Primary fetal tissue | Physiologically mature | Ethical concerns, limited supply |
| ESC-derived | Unlimited potential | Tumor risk, immune issues |
| iPSC-derived | Patient-specific, disease modeling | Cost, variability |
| Direct reprogramming | Fast conversion | Incomplete maturation |
The study of Ipsc Derived Motor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.